Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment

Magnus Lindh-Rengifo1, Stina B Jonasson2, Susann Ullén3

  • 1Department of Health Sciences, Faculty of Medicine, Lund University, Lund, Sweden.

PubMed
Abstract

Insights

Gait changes, specifically step velocity variability, are linked to tau pathology in individuals with mild cognitive impairment. This highlights the importance of assessing gait variability for early dementia detection.

Area of Science:

  • Neuroscience
  • Gerontology
  • Biomedical Engineering

Background:

  • Impaired gait is an early indicator of cognitive decline and dementia.
  • Understanding the link between brain pathologies and gait is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To investigate the association between Alzheimer's disease pathologies (amyloid-β and tau) and specific gait parameters in individuals with mild cognitive impairment (MCI).
  • To explore the relationship between white matter hyperintensities (WMH) and gait parameters in MCI patients.

Main Methods:

  • Cross-sectional study of 96 MCI patients (mean age 72).
  • Gait analysis using GAITRite® to measure step velocity variability, step length, step time, and stance time asymmetry.
  • Brain pathologies assessed via PET imaging (amyloid-β, tau) and MRI (WMH).

Main Results:

  • Increased tau-PET levels (Braak I-IV ROI) were significantly associated with higher step velocity variability and longer step length.
  • These associations remained significant after adjusting for WMH.
  • No significant associations were found between gait parameters and amyloid-β-PET load or WMH.

Conclusions:

  • Step velocity variability is a key gait parameter associated with tau pathology in MCI.
  • Assessing gait variability in single-task conditions may aid in identifying individuals at risk for dementia.
  • Further research with larger cohorts and dual-tasking assessments is recommended.

Related Concept Videos